Berkshire Asset Management’s Nucor NUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.9M Buy
360,065
+1,293
+0.4% +$225K 2.61% 8
2025
Q4
$58.5M Sell
358,772
-2,159
-0.6% -$324K 2.57% 8
2025
Q3
$48.9M Sell
360,931
-588
-0.2% -$83.2K 2.08% 12
2025
Q2
$46.8M Buy
361,519
+14,371
+4% +$1.68M 2.12% 13
2025
Q1
$40.1M Sell
347,148
-6,335
-2% -$816K 1.92% 17
2024
Q4
$43.2M Sell
353,483
-3,447
-1% -$496K 2.04% 13
2024
Q3
$56.4M Hold
356,930
2.87% 8
2024
Q2
$56.4M Buy
356,930
+18,569
+5% +$3.23M 2.81% 8
2024
Q1
$67M Sell
338,361
-4,603
-1% -$841K 3.55% 4
2023
Q4
$59.7M Sell
342,964
-5,980
-2% -$948K 3.4% 4
2023
Q3
$54.6M Sell
348,944
-3,779
-1% -$625K 3.4% 5
2023
Q2
$57.8M Buy
352,723
+2,518
+0.7% +$368K 3.43% 4
2023
Q1
$54.1M Sell
350,205
-4,183
-1% -$665K 3.34% 5
2022
Q4
$46.7M Buy
354,388
+5,443
+2% +$740K 3% 6
2022
Q3
$37.3M Buy
348,945
+9,864
+3% +$1.24M 2.64% 10
2022
Q2
$35.4M Buy
339,081
+11,569
+4% +$1.57M 2.31% 14
2022
Q1
$48.7M Buy
327,512
+7,932
+2% +$973K 3.07% 6
2021
Q4
$36.5M Buy
319,580
+7,559
+2% +$826K 2.22% 16
2021
Q3
$30.7M Buy
312,021
+867
+0.3% +$92.2K 2.06% 16
2021
Q2
$29.8M Buy
311,154
+27,778
+10% +$2.6M 2.02% 16
2021
Q1
$22.7M Sell
283,376
-25,775
-8% -$1.56M 1.69% 24
2020
Q4
$16.4M Buy
309,151
+9,552
+3% +$493K 1.26% 33
2020
Q3
$13.4M Sell
299,599
-35,546
-11% -$1.57M 1.3% 33
2020
Q2
$13.9M Buy
335,145
+24,815
+8% +$1M 1.28% 36
2020
Q1
$11.2M Buy
310,330
+7,861
+3% +$349K 1.16% 36
2019
Q4
$17M Sell
302,469
-996
-0.3% -$54.3K 1.45% 35
2019
Q3
$15.4M Sell
303,465
-1,898
-0.6% -$99.1K 1.33% 35
2019
Q2
$16.8M Sell
305,363
-688
-0.2% -$37.8K 1.39% 32
2019
Q1
$17.9M Buy
306,051
+1,108
+0.4% +$65K 1.52% 30
2018
Q4
$15.8M Buy
304,943
+11,237
+4% +$664K 1.48% 29
2018
Q3
$18.6M Buy
293,706
+16,393
+6% +$1.05M 1.58% 26
2018
Q2
$17.3M Buy
277,313
+9,862
+4% +$629K 1.62% 25
2018
Q1
$16.3M Buy
267,451
+12,010
+5% +$795K 1.59% 25
2017
Q4
$16.2M Buy
255,441
+25,033
+11% +$1.46M 1.57% 26
2017
Q3
$12.9M Buy
230,408
+75,899
+49% +$4.29M 1.44% 28
2017
Q2
$8.94M Buy
154,509
+2,353
+2% +$138K 1.02% 37
2017
Q1
$9.09M Buy
152,156
+6,839
+5% +$418K 1.08% 37
2016
Q4
$8.65M Buy
145,317
+726
+0.5% +$40.6K 1.12% 38
2016
Q3
$7.15M Buy
144,591
+6,413
+5% +$326K 1.03% 39
2016
Q2
$6.83M Sell
138,178
-710
-0.5% -$34.6K 1.04% 38
2016
Q1
$6.57M Buy
138,888
+10,491
+8% +$427K 1.02% 37
2015
Q4
$5.17M Sell
128,397
-13,198
-9% -$542K 0.86% 42
2015
Q3
$5.32M Buy
141,595
+15,334
+12% +$657K 0.95% 39
2015
Q2
$5.56M Buy
126,261
+5,209
+4% +$250K 0.93% 41
2015
Q1
$5.75M Buy
121,052
+15,489
+15% +$723K 0.96% 41
2014
Q4
$5.18M Buy
105,563
+6,632
+7% +$345K 0.89% 42
2014
Q3
$5.37M Buy
98,931
+14,998
+18% +$791K 0.99% 37
2014
Q2
$4.13M Sell
83,933
-5,137
-6% -$264K 0.77% 49
2014
Q1
$4.5M Sell
89,070
-4,843
-5% -$243K 0.87% 44
2013
Q4
$5.01M Buy
93,913
+18,579
+25% +$959K 0.95% 41
2013
Q3
$3.69M Buy
75,334
+13,143
+21% +$616K 0.89% 41
2013
Q2
$2.69M Buy
+62,191
New +$2.76M 0.75% 44

Other funds holding NUE

Berkshire Asset Management's NUE Position: Q1 2026 in Review

Berkshire Asset Management increased its Nucor (NUE) stake by 0.36% in Q1 2026, buying an estimated $225K and bringing the position to 360,065 shares worth $60.9M. The position accounts for 2.61% of the portfolio, ranked #8.

Berkshire Asset Management first reported a position in NUE in Q2 2013 and has held it in 52 quarters since. The position peaked at $67M in Q1 2024. 1,370 funds tracked by Wall St. Rank hold NUE as of Q1 2026.

  • Berkshire Asset Management held 360,065 shares of Nucor worth $60.9M as of Q1 2026.
  • Berkshire Asset Management bought 1,293 Nucor shares in Q1 2026, an estimated $225K.
  • Nucor made up 2.61% of Berkshire Asset Management's portfolio in Q1 2026, its #8 holding.
  • Berkshire Asset Management first reported a position in Nucor in Q2 2013 and has held it in 52 quarters since.
  • Berkshire Asset Management's Nucor position peaked at $67M in Q1 2024.
  • 1,370 funds tracked by Wall St. Rank held Nucor as of Q1 2026.

Based on Berkshire Asset Management's 13F filing for Q1 2026, filed 11 May 2026.